Medicofarma Biotech SA (WSE:MDB)
Poland · Delayed Price · Currency is PLN 0.4880
+0.0080 (1.67%)
At close: Apr 16, 2026
Medicofarma Biotech Revenue
In the year 2025, Medicofarma Biotech had annual revenue of 119.90K PLN, down -90.21%.
Revenue
119.90K
Revenue Growth
-90.21%
P/S Ratio
272.14
Revenue / Employee
8.56K
Employees
6
Market Cap
32.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 119.90K | -1.10M | -90.21% |
| Dec 31, 2024 | 1.22M | 474.05K | 63.14% |
| Dec 31, 2023 | 750.81K | -3.50M | -82.34% |
| Dec 31, 2022 | 4.25M | 915.81K | 27.45% |
| Dec 31, 2021 | 3.34M | -313.69K | -8.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.64B |
| Diagnostyka | 2.30B |
| Synektik Spólka Akcyjna | 706.45M |
| Celon Pharma | 225.60M |
| BioMaxima | 59.11M |
| Sygnis | 11.34M |
| genXone | 2.34M |
| Pharmena | 1.58M |